The company is now reportedly planning to offer 7 million shares at a price range of $24 to $25, up from the original planned offering of 6 million shares at $20 to $23. As such, the total amount raised could increase from approximately $129 million to $172 million.
The company will be traded on the Nasdaq stock market under the symbol HCAT. It is expected to go public on July 25.
More articles on data analytics:
Healthcare software company Phreesia goes public: 3 things to know
Atrium Health deploys automation, data analytics for medication management
How Johns Hopkins boosted data sharing between patients, clinicians: CMIO Dr. Peter Greene
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.